Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dominant Negative RAS as an anticancer agent.

Cancer biology & therapy - 1 Nov 2006

Guo Wei, Fang Bingliang

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, ras
Share to Genetic Therapy
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17204860
DOI: 10.4161/cbt.5.11.3681

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dominant Negative RAS as an anticancer agent.PMID 17204860Read ↗

Finding and drugging the vulnerabilities of RAS-dependent cancers.Semantic proximity Read ↗

Ras farnesyltransferase: a new therapeutic target.Semantic proximity Read ↗

New druggable targets in the Ras pathway?Semantic proximity Read ↗

Drugging RAS: Know the enemy.Semantic proximity Read ↗

Ras proteins as therapeutic targets.Semantic proximity Read ↗

Development and safety of investigational and approved drugs targeting the RAS function regulation in RAS mutant cancers.Semantic proximity Read ↗

Targeting oncogenic Ras.Semantic proximity Read ↗

RAS: Target for Cancer TherapySemantic proximity Read ↗

Inhibitors of the ERK mitogen-activated protein kinase cascade for targeting RAS mutant cancers.Semantic proximity Read ↗

The importance of Ras in drug resistance in cancerSemantic proximity Read ↗

Targeting the RAS oncogene.Semantic proximity Read ↗

Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.